$FXA
Invesco CurrencyShares Australian Dollar Trust

2023 Q1 Form 10-K Financial Statement

#000156459023002359 Filed on February 24, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $217.3K $187.4K
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $77.71K $367.4K
YoY Change -17.37% -32.98%
Operating Profit
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings $139.6K -$180.0K
YoY Change -248.4% -67.16%
Net Earnings / Revenue 64.23% -96.06%
Basic Earnings Per Share $0.12 -$0.14
Diluted Earnings Per Share $0.12 -$0.14
COMMON SHARES
Basic Shares Outstanding 1.200M 1.329M
Diluted Shares Outstanding 1.162M 1.329M

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $76.24M $87.26M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $76.32M $87.32M
YoY Change -10.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities $25.91K $6.739M
YoY Change 17131.76%
SHAREHOLDERS EQUITY
Retained Earnings $0.00 $0.00
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity
YoY Change
Total Liabilities & Shareholders Equity $76.32M $87.32M
YoY Change -10.39%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income $139.6K -$180.0K
YoY Change -248.4% -67.16%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $117.2K -$251.0K
YoY Change -217.7% -55.52%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid $117.9K $40.44K
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -10.17M -2.596M
YoY Change -18610.02% -94.97%
NET CHANGE
Cash From Operating Activities 117.2K -251.0K
Cash From Investing Activities
Cash From Financing Activities -10.17M -2.596M
Net Change In Cash -11.03M -10.18M
YoY Change -456.03% -83.1%
FREE CASH FLOW
Cash From Operating Activities $117.2K -$251.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Security Exchange Name
SecurityExchangeName
NYSEArca
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
95760000
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1200000
CY2021 us-gaap Sponsor Fees
SponsorFees
548255
CY2022 dei Entity Registrant Name
EntityRegistrantName
Invesco CURRENCYSHARES AUSTRALIAN DOLLAR TRUST
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.30
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001353614
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
CY2022 fxa Share Purchase And Redemptions Settlement Period Creation And Redemption
SharePurchaseAndRedemptionsSettlementPeriodCreationAndRedemption
P2D
CY2021Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-32911
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NY
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-4685355
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
3500 Lacey Road
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 700
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Downers Grove
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60515
CY2022 dei City Area Code
CityAreaCode
800
CY2022 dei Local Phone Number
LocalPhoneNumber
983-0903
CY2022 dei Security12b Title
Security12bTitle
Common Units of Beneficial Interest
CY2022 dei Trading Symbol
TradingSymbol
FXA
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Auditor Firm
AuditorFirmId
238
CY2022 dei Auditor Name
AuditorName
PricewaterhouseCoopers LLP
CY2022 dei Auditor Location
AuditorLocation
Chicago, Illinois
CY2022Q4 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
87260857
CY2021Q4 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
97441463
CY2022Q4 us-gaap Due From Banks
DueFromBanks
931
CY2021Q4 us-gaap Due From Banks
DueFromBanks
0
CY2022Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
58317
CY2021Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
0
CY2022Q4 us-gaap Assets
Assets
87320105
CY2021Q4 us-gaap Assets
Assets
97441463
CY2022Q4 us-gaap Preferred Stock Redemption Amount
PreferredStockRedemptionAmount
6712374
CY2021Q4 us-gaap Preferred Stock Redemption Amount
PreferredStockRedemptionAmount
0
CY2022Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
26450
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
39107
CY2022Q4 us-gaap Liabilities
Liabilities
6738824
CY2021Q4 us-gaap Liabilities
Liabilities
39107
CY2022Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
1200000
CY2022Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
1200000
CY2021Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
1350000
CY2021Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
1350000
CY2022Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
80581281
CY2021Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
97402356
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
0
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
0
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
87320105
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
97441463
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
187406
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
0
CY2022 us-gaap Revenues
Revenues
187406
CY2021 us-gaap Revenues
Revenues
0
CY2022 us-gaap Sponsor Fees
SponsorFees
367429
CY2022 us-gaap Operating Expenses
OperatingExpenses
367429
CY2021 us-gaap Operating Expenses
OperatingExpenses
548255
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-180023
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-548255
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.30
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1329315
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1329315
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1823151
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1823151
CY2022 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
40442
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-180023
CY2022 us-gaap Reclassifications Of Temporary To Permanent Equity
ReclassificationsOfTemporaryToPermanentEquity
220465
CY2021 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-16024
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-548255
CY2021 us-gaap Reclassifications Of Temporary To Permanent Equity
ReclassificationsOfTemporaryToPermanentEquity
548255
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-180023
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-250997
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-548255
CY2022 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
58317
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-564279
CY2022 us-gaap Payments Of Capital Distribution
PaymentsOfCapitalDistribution
40442
CY2021 us-gaap Payments Of Capital Distribution
PaymentsOfCapitalDistribution
0
CY2021 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
0
CY2022 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-12657
CY2022 us-gaap Proceeds From Issuance Of Redeemable Preferred Stock
ProceedsFromIssuanceOfRedeemablePreferredStock
24428829
CY2021 us-gaap Proceeds From Issuance Of Redeemable Preferred Stock
ProceedsFromIssuanceOfRedeemablePreferredStock
11566005
CY2022 us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
26984531
CY2021 us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
63174072
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2596144
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-51608067
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-7332534
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-8052420
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-10179675
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-60224766
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
97441463
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
157666229
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
87261788
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
97441463
CY2022 us-gaap Interest Paid Net
InterestPaidNet
0
CY2021 us-gaap Interest Paid Net
InterestPaidNet
0
CY2022 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2006-06-08
CY2022Q4 fxa Initial Incorporation Deposit With Bank Sponsor
InitialIncorporationDepositWithBankSponsor
100
CY2022 fxa Number Of Deposits Accounts In Which Trust Assets Primarily Consist Demand Deposit
NumberOfDepositsAccountsInWhichTrustAssetsPrimarilyConsistDemandDeposit
2
CY2022 fxa Stock Redeemable In Baskets Number Of Shares
StockRedeemableInBasketsNumberOfShares
50000
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:3.33%;white-space:nowrap" valign="top"> <p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:bold;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:bold;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">B.</span></p></td> <td valign="top"> <p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:bold;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="font-weight:normal;color:#000000;"/><span style="font-size:10pt;color:#000000;">Accounting Estimates</span></p></td></tr></table></div> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates by a significant amount. In addition, the Trust monitors for material events or transactions that may occur or become known after the period-end date and before the date the financial statements are issued.</p>
CY2022 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.03
CY2022 us-gaap Payments Of Dividends
PaymentsOfDividends
40442
CY2022Q4 us-gaap Dividend Payable Date To Be Paid Day Month And Year
DividendPayableDateToBePaidDayMonthAndYear
2023-01-10
CY2022Q4 us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2023-01-04
CY2022Q4 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.02741
CY2022Q4 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
32892
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022 fxa Minimum Period Required To Stay For Tax Liability
MinimumPeriodRequiredToStayForTaxLiability
P183D
CY2022Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.0087
CY2022Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.0087
CY2022 us-gaap Proceeds From Issuance Of Redeemable Preferred Stock
ProceedsFromIssuanceOfRedeemablePreferredStock
34667570
CY2022 us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
49506491
CY2022 us-gaap Payments For Operating Activities
PaymentsForOperatingActivities
407222
CY2022Q4 us-gaap Cash
Cash
118776794
CY2022Q4 us-gaap Cash
Cash
80548483
CY2021 us-gaap Proceeds From Issuance Of Redeemable Preferred Stock
ProceedsFromIssuanceOfRedeemablePreferredStock
14935112
CY2021 us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
84490117
CY2021 us-gaap Payments For Operating Activities
PaymentsForOperatingActivities
745508
CY2021Q4 us-gaap Cash
Cash
134022937
CY2021Q4 us-gaap Cash
Cash
97441463

Files In Submission

Name View Source Status
0001564590-23-002359-index-headers.html Edgar Link pending
0001564590-23-002359-index.html Edgar Link pending
0001564590-23-002359.txt Edgar Link pending
0001564590-23-002359-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
fxa-10k_20221231.htm Edgar Link pending
fxa-10k_20221231_htm.xml Edgar Link completed
fxa-20221231.xsd Edgar Link pending
fxa-ex231_9.htm Edgar Link pending
fxa-ex311_6.htm Edgar Link pending
fxa-ex312_8.htm Edgar Link pending
fxa-ex321_10.htm Edgar Link pending
fxa-ex322_7.htm Edgar Link pending
g04wlbxrrglb000001.jpg Edgar Link pending
g04wlbxrrglb000002.jpg Edgar Link pending
g04wlbxrrglb000003.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
fxa-20221231_lab.xml Edgar Link unprocessable
fxa-20221231_pre.xml Edgar Link unprocessable
fxa-20221231_def.xml Edgar Link unprocessable
fxa-20221231_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable